Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis). (Q50895051)

24 March 2018

title

Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis). (English)

1 reference

24 March 2018

author name string

Marzieh Niknami

1 reference

24 March 2018

Min-Xia Wang

1 reference

24 March 2018

Toan Nguyen

1 reference

24 March 2018

John D Pollard

1 reference

24 March 2018

publication date

1 June 2013

1 reference

24 March 2018

Journal of the Peripheral Nervous System

published in

1 reference

24 March 2018

volume

1 reference

24 March 2018

issue

1 reference

24 March 2018

page(s)

141-152

1 reference

24 March 2018

Are aggregates of IgG the effective part of high-dose immunoglobulin therapy in adult idiopathic thrombocytopenic purpura (ITP)?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Protective mechanisms of IVIG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Human immunoglobulin ameliorates rat experimental autoimmune neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Patterns of conduction impairment in experimental allergic neuritis. An electrophysiological and histological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Aggregated immunoglobulin and Fc fragment of IgG induce IL-6 release from human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Expression and function of the inhibitory Fcγ-receptor in CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Fcgamma receptors: old friends and new family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

The antiinflammatory activity of IgG: the intravenous IgG paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Fcgamma receptors as regulators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Myelination in rat brain: method of myelin isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Immunomodulatory action of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Treatment of inflammatory muscle disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Lumbar-spinal somatosensory evoked potentials in the rat after stimulation of the tibial nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

IgG1 and IVIg induce inhibitory ITAM signaling through Fc RIII controlling inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNS5.12022

21 January 2018

Identifiers

DOI

10.1111/JNS5.12022

1 reference

24 March 2018

1 reference

24 March 2018